Interventional Systems
Private Company
Funding information not available
Overview
Interventional Systems is a private medical robotics company commercializing its FDA-cleared and CE-marked Micromate™ platform. The system is a vendor-agnostic, instrument-agnostic robotic assistant for percutaneous interventions, offering submillimeter accuracy and a turnkey solution designed for ease of use and affordability. With a focus on interventional oncology and radiology, the company is in the early revenue stage, leveraging a commercial licensing and distribution model to expand access to robotic-assisted procedures globally.
Technology Platform
Micromate™: A compact, table-mounted, imaging- and instrument-agnostic robotic system for precise needle guidance in percutaneous interventions. It combines a direct-table-connection robotic arm with proprietary planning/navigation software and a disposable patient positioning system (iFIX).
Opportunities
Risk Factors
Competitive Landscape
Competes in the robotic-assisted surgery space, specifically against other needle guidance robots (e.g., some offerings from larger robotics firms) and advanced navigation systems. Its main differentiation is its compact, table-mounted, vendor-agnostic design aimed at affordability and workflow integration, setting it apart from larger, more generalized surgical robots.